Mcp and Hyperthyroidism - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism is reported as a side effect among people who take Mcp (pectin), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Carboplatin, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Hyperthyroidism when taking Mcp. It is created by eHealthMe based on reports of 2,073 people who have side effects when taking Mcp from the FDA, and is updated regularly.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

What is Hyperthyroidism?

Hyperthyroidism (over activity of the thyroid gland) is found to be associated with 1,057 drugs and 1,415 conditions by eHealthMe. Check the latest studies of Hyperthyroidism.

On Jul, 23, 2025

2,073 people reported to have side effects when taking Mcp.
Among them, 15 people (0.72%) have Hyperthyroidism.

Among these 15 people:

How long have people been on Mcp when they have Hyperthyroidism? *

What is the gender of people who have Hyperthyroidism when taking Mcp? *

female: 40 %
male: 60 %

What is the age of people who have Hyperthyroidism when taking Mcp? *

What are other drugs people take besides Mcp? *

What are other side effects people have besides Hyperthyroidism? *

Diarrhea: 8 people, 53.33%
Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 40.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 40.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 26.67%
Cholangitis (infection of the bile duct): 3 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Weight Decreased: 3 people, 20.00%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 20.00%
Death: 3 people, 20.00%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 10 people, 66.67%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 6 people, 40.00%
Pain: 3 people, 20.00%
Malignant Neoplasm Progression (cancer tumour came back): 3 people, 20.00%
Rashes (redness): 1 person, 6.67%
Otitis Media (inflammation of the middle ear): 1 person, 6.67%
Otitis (ear infection): 1 person, 6.67%
Nausea And Vomiting: 1 person, 6.67%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 6.67%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mcp and have Hyperthyroidism?

- Check whether Hyperthyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mcp:

Mcp (2,077 reports)

Hyperthyroidism treatments and more:

Hyperthyroidism (26,827 reports)

How severe was Hyperthyroidism and when was it recovered:

Hyperthyroidism in Mcp

Browse all side effects of Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism:

Hyperthyroidism (1,057 drugs)

Browse all the conditions that are associated with Hyperthyroidism:

Hyperthyroidism (1,415 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on pectin (the active ingredients of Mcp) and Mcp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.